Ciprofloxacin
Back to searchMolecule Structure
Scientific Name
Ciprofloxacin
Description of the Drug
Ciprofloxacin is a second generation fluoroquinolone used to treat various susceptible bacterial infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00537
http://www.drugbank.ca/drugs/DB00537
Brand Name(s)
Cetraxal, Ciloxan, Cipro, Ciprobay, Ciprofloxacin, Otiprio, Velmonit
Company Owner(s)
Inforlife Sa, Anchen Pharmaceuticals, Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Chartwell Life Molecules Llc, Novartis Pharmaceuticals Corp, Amneal Pharmaceuticals Llc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Depomed Inc, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2311224 |
| Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL2363076 |
Clinical Trial(s)
Unichem Links
| Atlas | ciprofloxacin | ||||||
| SureChEMBL | SCHEMBL2900 | ||||||
| PharmGKB | PA449009 | ||||||
| Human Metabolome Database | HMDB0014677 | ||||||
| DrugBank | DB00537 | ||||||
| PubChem: Thomson Pharma | 14777502 | ||||||
| PubChem | 2764 | 4011971 | |||||
| Mcule | MCULE-8631780654 | ||||||
| NMRShiftDB | 60058704 | ||||||
| LINCS | LSM-5226 | ||||||
| Nikkaji | J21.732H | ||||||
| PDBe | CPF | ||||||
| BindingDB | 21690 | ||||||
| EPA CompTox Dashboard | DTXSID8022824 | ||||||
| DrugCentral | 659 | ||||||
| Brenda | 1229 | 229281 | 229280 | ||||
| ChemicalBook | CB52630301 | CB22670034 | |||||
| Guide to Pharmacology | 10902 | ||||||
| rxnorm | PROQUIN | CIPROFLOXACIN HYDROCHLORIDE | CIPRO | OTIPRIO | CETRAXAL | CIPROFLOXACIN | CILOXAN |
| KEGG Ligand | C05349 | ||||||
| ChEBI | 192484 | 100241 | |||||
| ZINC | ZINC000000020220 |
